Shanghai Rendu Biotechnology Co., Ltd. (SHA:688193)
China · Delayed Price · Currency is CNY 52.19
+2.23 (4.46%)
Sep 30, 2026, 4:00 PM EDT
SHA:688193 Revenue
Shanghai Rendu Biotechnology had revenue of 37.36M CNY in the quarter ending June 30, 2026, a decrease of -7.89%. This brings the company's revenue in the last twelve months to 160.14M, down -6.85% year-over-year. In the year 2025, Shanghai Rendu Biotechnology had annual revenue of 161.94M, down -8.69%. That makes Shanghai Rendu Biotechnology the world's 32,728th largest company by revenue and 5,060th in China.
Revenue (ttm)
160.14M
Revenue Growth
-6.85%
P/S Ratio
12.64
Revenue / Employee
681.44K
Employees
235
Market Cap
2.02B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 161.94M | -15.41M | -8.69% |
| Dec 31, 2024 | 177.35M | 12.94M | 7.87% |
| Dec 31, 2023 | 164.41M | -139.44M | -45.89% |
| Dec 31, 2022 | 303.85M | 11.54M | 3.95% |
| Dec 31, 2021 | 292.31M | 42.40M | 16.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Runda Medical Technology | 6.72B |
| Maccura Biotechnology Co.Ltd | 2.13B |
| Medicalsystem Biotechnology | 1.63B |
| Beijing Strong Biotechnologies,Inc. | 1.37B |
| Shanghai Labway Clinical Laboratory | 1.28B |
| Berry Genomics Co.,Ltd | 929.15M |
| Thalys Medical Technology Group | 836.23M |
| SMO ClinPlus CO.,LTD. | 824.77M |